Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor alpha6beta2delta subtype (α6β2δ GABAAR)

Target
α6β2δ GABAAR
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Cys-loop superfamily
01

Overview

The GABA_A receptor α6β2δ subtype is a specific heteropentameric assembly of the gamma-aminobutyric acid type A receptor, primarily localized to the extrasynaptic membranes of cerebellar granule cells [2, 9]. Unlike synaptic GABA_A receptors that mediate fast phasic inhibition, the α6β2δ subtype is characterized by high GABA affinity and slow desensitization, making it a key mediator of tonic inhibition which regulates the baseline excitability of neurons [3, 12, 13]. This subtype plays a crucial role in motor learning and the filtering of sensory information entering the cerebellum [2, 3]. Dysregulation or hypofunction of α6-containing receptors is linked to various neuropsychiatric conditions, including essential tremor, migraine, and stress-related disorders [2, 9]. Pharmacologically, these receptors are distinct because they are insensitive to classical benzodiazepines like diazepam but can be modulated by neurosteroids such as THDOC, certain pyrazoloquinolinones like CGS 9895, and the ligand Ro15-4513 [4, 11, 12]. Targeting this specific subtype offers a potential therapeutic avenue for treating cerebellar-related motor and cognitive deficits with reduced side effects compared to broad-spectrum GABAergic drugs [2, 6].

Other names
alpha6beta2delta GABA-A receptorα6β2δ GABA-A receptorExtrasynaptic alpha6-containing GABA-A receptorGABRA6-GABRB2-GABRD complex
02

Mechanism of action

Positive allosteric modulation or direct activation of the chloride ion channel, leading to increased chloride influx, membrane hyperpolarization, and tonic inhibition of neuronal activity [1, 3, 12].

03

Biological functions

Tonic inhibitionSignal transductionRegulation of neuronal excitabilityMotor learningSensory input filtering
04

Disease associations

Essential tremorMigraineTrigeminal neuralgiaNeuropsychiatric disorderStress-associated disorderAngelman syndromeDown syndromeEpilepsy
05

Safety considerations

Potential for motor coordination impairmentRisk of exacerbating symptoms in gain-of-function GABRD mutationsOff-target effects on other GABAAR subtypes if selectivity is low
06

Interacting drugs

GABA

8 more in the full profile.

07

Biomarkers

GABRA6 expression levelsGABRB2 expression levelsGABRD expression levels[11C]Ro15-4513 PET bindingTonic inhibitory current density

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor alpha6beta2delta subtype (α6β2δ GABAAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha6beta2delta subtype (α6β2δ GABAAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call